Sapient Capital’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Sapient Capital's AMGN Position: Q2 2026 in Review
Sapient Capital reduced its Amgen (AMGN) stake by 24% in Q2 2026, selling an estimated $295K and leaving 2,757 shares worth $998K. The position accounts for 0.01% of the portfolio, ranked #200.
Sapient Capital first reported a position in AMGN in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.52M in Q4 2025. 3,143 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Sapient Capital held 2,757 shares of Amgen worth $998K as of Q2 2026.
- Sapient Capital sold 863 Amgen shares in Q2 2026, an estimated $295K.
- Amgen made up 0.01% of Sapient Capital's portfolio in Q2 2026, its #200 holding.
- Sapient Capital first reported a position in Amgen in Q4 2023 and has held it in 11 quarters since.
- Sapient Capital's Amgen position peaked at $1.52M in Q4 2025.
- 3,143 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Sapient Capital's 13F filing for Q2 2026, filed 9 Jul 2026.